Earlier this month, the Food and Drug Administration (FDA) held public hearings to better understand the role of, and the risks associated with, the promotion and marketing of FDA-regulated products using the Internet and social media. The last such hearing of this kind (which focused solely on the Internet) was organized by the FDA in
Food and Drug Administration (FDA)
Allergan Complaint to allow certain off-label drug promotion
By Adam Snukal on
In what could be a watershed case between a pharmaceutical company and the FDA, Allergan has filed suit against the FDA in the U.S. District Court for the District of Columbia, seeking a ruling from the court that would allow Allergan to share relevant information about the safe use of BOTOX with the medical community…
Cheerios – a Drug?
By Adam Snukal on
General Mills is the Food and Drug Administration’s ("FDA") latest target. In case you think that you misread the previous statement, General Mills—manufacturer of the popular cereal "Cheerios"—received a letter addressed to its Chairman from the FDA May 5 claiming that the FDA has reviewed various Cheerios labels and found they contain "serious violations" of federal…
No Cold Meds for Kids Under 4, Companies Say
By John P. Feldman on
Children under the age of 4 should not be given over-the-counter (OTC) cold remedies, according to new labeling being prepared by leading cold medicine manufacturers.
The manufacturers of medicines sold under brands such as Dimetapp, Pediacare, Robitussin, Triaminic and Little Colds have agreed to voluntarily change their labels to state “do not use” for children…
Battle Over Baby Bottle Plastic Rages On
By John P. Feldman on
When it comes to the risk posed by bisphenol-A (BPA), the chemical used to make hardened plastic containers such as baby bottles, liners for canned goods, and other plastic items, government officials can’t seem to agree.
In September, the National Toxicology Program (NTP), which is part of the National Institutes of Health, released a report…